Changes in immunological reactivity of patients with pulmonary tuberculosis and allergic and toxic-allergic reactions
Abstract
BACKGROUND. The spread of tuberculosis in Ukraine forces doctors to use intensive chemotherapy, which leads to adverse reactions and promotes to the spread of drug-resistant tuberculosis. Toxic-allergic reactions take a protracted course and are difficult to respond to corrective therapy, which requires additional research.
OBJECTIVE. To determine changes in immunological reactivity in patients with pulmonary tuberculosis with allergic and toxic-allergic reactions by cellular immunity research.
MATERIALS AND METHODS. The results of clinical, laboratory and immunological examination of patients were analyzed depending on the presence/absence of clinical signs of allergic reactions to antituberculosis drugs using the method of flow cytofluorimetry and assessment of phagocytic link of immunity.
RESULTS AND DISCUSSION. There were detected the activation of all studied subpopulations of T- and B-lymphocytes and an increase in the absolute and percentage number of natural killers in the blood of patients without adverse reactions. It is a positive factor for the destruction of mycobacteria. The development of allergic reactions support the inhibition of the activity of the general pool of T-lymphocytes, their subpopulations, B-lymphocytes, natural killers, the absorption activity of phagocytes. It is an unfavorable factor that can lead to the formation of anergy of immunocytes. Increased activity of the inflammatory process and deepening of the immunological imbalance were detected in patients with clinical and laboratory signs of toxic-allergic reactions. It is not accompanied by an inhibitory effect on blood lymphocytes and phagocytes, is revealed. It indicates a special pathogenesis of toxic-allergic reactions with involvement of disturbed liver functions.
CONCLUSSION. Identified differences in the immune status will allow to adjust the treatment.
References
Feshchenko Yu.I. ta in. Vedennia pobichnykh reaktsii pid chas likuvannia khvorykh na tuberkuloz ta koinfektsiiu (tuberkuloz/VIL-infektsiia/SNID). Metodychnyi posibnyk. MOZ Ukrainy, NAMN Ukrainy, DU “Natsionalnyi instytut ftyziatrii i pulmonolohii im. F.G. Yanovskoho NAMN Ukrainy”, 2016. 79 p.
Feshchenko Yu.I. ta in.Vedennia pobichnykh reaktsii pid chas likuvannia khvorykh na tuberkuloz ta koinfektsiiu (tuberkuloz/VIL-infektsiia/SNID). Tuberkuloz, lehenevi khvoroby, VIL-infektsiia. 2017; 4: 13-24.
Ivanova D.A., Borisov S.E. Spektr i faktory riska nezhelatelnykh pobochnykh reaktsyi pri lechenii vpervye vyiavlennykh bolnykh tuberkulezom. Tuberkulez i bolezni lehkikh. 2017; 95 (6): 22-29.
Rekalova O.M. ta in. Imunolohichni pokaznyky yak indykatory zapalnykh protsesiv u khvorykh na khronichne obstruktyvne zakhvoriuvannia lehen ta khronichnyi bronkhit u fazi remisii. Ukr. pulmonol. zhurn. 2016; 3: 30-34.
Simonova A.V. i dr. Intensivnost immunoflyuorestsentsii kak odin iz pokazateley pri fenotipirovanii limfotsitov perifericheskoy krovi patsientov s razlichnymi narusheniyami immuniteta. Immunologiya. 1996; 1: 42-45.
Kaidashev Y.P. Hiperchuvstvitelnost k lekarstvennym preparatam: rukovodstvo dlia vrachei. Kyiv: Medknyha, 2016. 288 p.
Kuzhko M.M, Prosvietov Yu.V., Hulchuk N.M. Osoblyvosti vynyknennia ta perebihu alerhichnykh i toksyko-alerhichnykh uskladnen na antymikobakterialni preparaty u khvorykh na tuberkuloz lehen. Astma ta alerhiia. 2009; 1-2: 38-43.
Mishin V.Yu., Chukanov V.I., Grigorev Yu.G. Pobochnoe deistvie protivotuberkuleznykh preparatov pri standartnykh i individualizirovannykh rezhimakh khimioterapii. Moskva: Kompiuterburg, 2004. 208 p.
Nakaz № 916 vid 30.12.2015 r. MOZ Ukrainy: “Medykamentozna alerhiia, vkliuchaiuchy anafilaksiiu. Adaptovana klinichna nastanova, zasnovana na dokazakh”. 207 p.
Lapovets N.Ye. ta in. Osoblyvosti imunnoho statusu khvorykh na multyrezystentnyi tuberkuloz lehen pislia zastosuvannia rezhymiv likuvannia z bedakvilinom ta linezolidom. Tuberkuloz. Lehenevi khvoroby. VIL-infektsiia. 2021; 3 (46): 30-35.
Kuzhko M.M. ta in. Pobichni reaktsii na protytuberkulozni preparaty i shliakhy yikh usunennia. Infusion & Chemotherapy. 2020; 4: 13-16.
Pinegin B.V. i dr. Primenenie protochnoy tsitometrii dlya otsenki funktsionalnoy aktivnosti immunnoy systemy cheloveka: posobye dlia vrachey-laborantov. Moskva: HNTsYMMRF, 2001. 53 p.
Pukhlyk B.M., Viktorov A.P., Zaikov S.V. Lekarstvennaya allergiya i pobochnye effekty lekarstvennykh sredstv v allergologii. Lviv: Medytsyna svitu, 2008. 108 p.
Feshchenko Yu.I. ta in. Reiestratsiia pobichnykh reaktsii protytuberkuloznykh preparativ pry likuvanni khvorykh na tuberkuloz. Ukr. pulmonol. zhurn. 2008; 4: 8-13.
Melnyk V.M. ta in. Sytuatsiia z retsydyvamy tuberkulozu lehen: pohliad ukrainskykh uchenykh. Infuziia & Khimioterapiia. 2021; 1: 22-27.
“Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy doroslym”: Nakaz MOZ Ukrainy vid 04.09.2014 r. № 620. Kyiv, 2014. 128 p.
Feshchenko Yu.I., Melnyk V.M., Opanasenko M.S. Neefektyvne likuvannia khvorykh na tuberkuloz lehen i yoho poperedzhennia. Kyiv: Lira-K, 2019. 246 p.
Lehmann A.K., Sørnes S., Halstensen A. Phagocytosis: measurement by flow cytometry. J. of Immunological Methods. 2000; vol. 243, № 1-2: 229-242.
Middletons Allergy Essentials: © 2017, Elsevier Inc. 409 p.
Zaikov S., Bogomolov A., Gryshylo A. Hypersensitivity to antituberculosis drugs in patients with pulmonary tuberculosis. Allergy. 2019; 74: 749.
Zaikov S., Bogomolov A., Gryshylo A. Hypersensitive reactions to antituberculosis drugs. Allergy. 2018; 73: 211-212.
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 
ISSN 
